Prospective cohort study evaluating efficacy and safety of efgartigimod in Chinese generalized myasthenia gravis patients.

MLA

Pan Wang, et al. “Prospective Cohort Study Evaluating Efficacy and Safety of Efgartigimod in Chinese Generalized Myasthenia Gravis Patients.” Frontiers in Neurology, July 2024, pp. 1–7. EBSCOhost, https://doi.org/10.3389/fneur.2024.1407418.

APA

Pan Wang, Bo Zhang, Jian Yin, Jianying Xi, Ying Tan, Feng Gao, Fan Zeng, Ting Chang, Hao Zhou, Hui Liang, Zhongyan Zhao, Huan Yang, Chongbo Zhao, & Shixiong Huang. (2024). Prospective cohort study evaluating efficacy and safety of efgartigimod in Chinese generalized myasthenia gravis patients. Frontiers in Neurology, 1–7. https://doi.org/10.3389/fneur.2024.1407418

Chicago

Pan Wang, Bo Zhang, Jian Yin, Jianying Xi, Ying Tan, Feng Gao, Fan Zeng, et al. 2024. “Prospective Cohort Study Evaluating Efficacy and Safety of Efgartigimod in Chinese Generalized Myasthenia Gravis Patients.” Frontiers in Neurology, July, 1–7. doi:10.3389/fneur.2024.1407418.